Kapiva Partners with CCRAS to Commercialise Clinically Evaluated Ayurvedic Formulations

Kapiva Partners with CCRAS to Commercialise Clinically Evaluated Ayurvedic Formulations

Kapiva and CCRAS have entered a strategic alliance to commercialise 10 clinically evaluated Ayurvedic formulations, combining public research, scientific data and modern consumer-friendly product formats.

 

Kapiva, one of India’s most trusted science-backed Ayurvedic brands, has entered into a strategic technology transfer and commercialisation alliance with the Central Council of Research in Ayurvedic Sciences (CCRAS), an apex research body under the Ministry of AYUSH, Government of India, to bring clinically evaluated Ayurvedic technologies and formulations to a wider consumer base.

Under the agreement, CCRAS will provide Kapiva access to its proprietary Ayurvedic formulations, scientific intellectual property, standardisation and manufacturing protocols, along with supporting pre-clinical and clinical data. The partnership will initially cover 10 products across health areas including pain, stress, metabolic health, sleep, liver health and respiratory health.

Kapiva will lead the next stage of product development and commercialisation, including adaptation into modern consumer-friendly formats, manufacturing at scale, branding and nationwide distribution. The brand will undertake formulation adaptation and product optimisation across areas such as taste, shelf-life, delivery formats and consumer convenience. Where a dosage form is changed, appropriate dose-equivalence studies will be conducted.

The strategic alliance connects public sector research with commercial distribution, translating CCRAS’s clinical formulations into daily consumer use. Kapiva intends to take formulations and technologies that have already undergone scientific and clinical evaluation through CCRAS and its research ecosystem and make them available to consumers in formats that are easier to adopt in everyday life.

Read More Knee Preservation Therapy Offers New Option for Mild to Moderate Knee OA Patients

Ameve Sharma, Founder & CEO, Kapiva, said, “There is a tremendous body of Ayurvedic research that has already been developed and clinically evaluated within India’s public research ecosystem. Our role is to take that science to more people. Through this partnership with CCRAS, we want to bring scientifically studied Ayurvedic formulations to consumers in modern, convenient formats without compromising the core formulation or evidence behind them. It is an important step towards making credible, research-led Ayurveda more accessible at scale.”

Read More MRG Group Expands MRG Crown Clubhouse to 30,000 Sq. Ft. with Club Jewel

Prof. Vaidya Rabinarayan Acharya, Director General, CCRAS, said, “The partnership reflects CCRAS’ larger objective of enabling the transfer and commercialisation of validated Ayurvedic technologies so that research developed within the public system can translate into products that benefit a wider population. Collaboration with industry partners such as Kapiva can help take these technologies from research to large-scale consumer access while maintaining the scientific and quality standards established by CCRAS.”

Read More BRICS+ Dialogue 2026 in New Delhi Pushes Global South Cooperation Beyond Dialogue

The collaboration is in line with the Ministry of AYUSH’s broader approach towards technology transfer and commercialisation of Ayurvedic research and demonstrates how public research institutions and private-sector brands can work together to bring scientifically backed Ayurvedic solutions to consumers at scale.

Earlier this year, Kapiva launched the Kapiva Innovation Fund to support research and innovation in Ayurveda. The brand also launched Kapiva Ayurveda Clinics in Bengaluru to bring structured, evidence-led Ayurvedic care closer to consumers. Together with the CCRAS partnership, these initiatives reflect Kapiva’s broader focus on combining authentic Ayurveda with modern science, research and clinically informed product development.

Kapiva is a homegrown science-backed Ayurveda brand on a mission to make evidence-based Ayurveda simple, modern and accessible for everyday wellness. Backed by a dedicated R&D vertical of scientists and researchers, Kapiva develops authentic formulations using science-backed Ayurveda, standardised herbs and high-quality ingredients. Kapiva has been a disruptor in the Ayurvedic industry by introducing innovation in product formats that can be easily integrated into people’s daily routines. Kapiva has expanded globally with its wholly owned subsidiaries in the USA and Middle East, and has a strong offline presence across 50,000+ stores in India. One of India’s most trusted Ayurveda brands.

For more information, please visit the Kapiva website.

The Central Council for Research in Ayurvedic Sciences (CCRAS) is an autonomous body of the Ministry of Ayush, Government of India. It is an apex body in India for the formulation, coordination, development and promotion of research on scientific lines in the Ayurveda of medicine.

For more information, please visit the CCRAS website.

The agreement brings together CCRAS’s research and scientific resources with Kapiva’s product development, manufacturing, branding and nationwide distribution capabilities, creating a pathway for 10 clinically evaluated Ayurvedic products to reach consumers in modern formats while retaining the core formulation and evidence behind them.

Tags:

About The Author

Post Comment

Comment List

Latest News

Shehzad Poonawalla Set for Reality TV Debut With Rise and Fall Season 2 Shehzad Poonawalla Set for Reality TV Debut With Rise and Fall Season 2
Shehzad Poonawalla is set to make his reality TV debut with Rise and Fall Season 2 after leaving the BJP,...
Supreme Court Orders IOC to Pay ₹12 Lakh to Woman Denied LPG Plant Job
India’s UPI Fee Shift Puts Free Digital Payments Model Under Fresh Scrutiny

Live Cricket Score

Advertisement

Science & Tech

Apple Foldable iPhone Raises Questions Over Price, Purpose and Target Buyer Apple Foldable iPhone Raises Questions Over Price, Purpose and Target Buyer
Apple’s new foldable iPhone Duo starts at $1,999, but analysts question its target audience, purpose and long-term appeal as foldable...
Apple iPhone 18 Pro Max Launch Tonight: Foldable iPhone Could Steal the Show

Health

Coffee-Based Home Remedies Gain Ground as Dermatologists Highlight Natural Skincare Benefits Coffee-Based Home Remedies Gain Ground as Dermatologists Highlight Natural Skincare Benefits
A growing number of dermatologists are endorsing coffee-based home remedies as natural, affordable alternatives to commercial skincare. From face scrubs...
Moringa’s Rise as a Global Superfood Gains Momentum Amid New Research

Lifestyle

 Food Pharmer Sparks Nationwide Debate Over Cheeslings Ingredients, Raises Questions on Food Safety Standards Food Pharmer Sparks Nationwide Debate Over Cheeslings Ingredients, Raises Questions on Food Safety Standards
Food influencer Revant Himatsingka, known as Food Pharmer, has sparked nationwide debate after revealing Cheeslings’ low cheese content and high...
From Gym Floor to City Streets: The Unexpected Revival of the Lopifit Treadmill-Bike
crossorigin="anonymous">